Michael Weiser

Michael Weiser has an estimated net worth of $55 Million. This is based on reported shares across multiple companies, which include ZIOPHARM ONCOLOGY INC, SEWARD SCIENCES, INC., KANAI SCIENCES, INC., KODIAK SCIENCES, INC., Innovive Pharmaceuticals, Inc., Paramount Acquisition Corp, IOVANCE BIOTHERAPEUTICS, INC., MANHATTAN PHARMACEUTICALS INC, EMISPHERE TECHNOLOGIES INC, Hana Biosciences Inc, IVORY CAPITAL CORP, and CHIRAL QUEST INC.

2006 was Michael Weiser's most active year for acquiring shares with 21 total transactions. Michael Weiser's most active month to acquire stocks was the month of April. 2017 was Michael Weiser's most active year for disposing of shares, totalling 5 transactions. Michael Weiser's most active month to dispose stocks was the month of November. 2012 saw Michael Weiser paying a total of $139,774.38 for 93,112 shares, this is the most they've acquired in one year. In 2008 Michael Weiser cashed out on 13,921 shares for a total of $2,631,000.00, their largest year based on trade value.